American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research filed a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership positions in Harmony Biosciences Holdings, Inc. common stock as of September 30, 2026.

Key Highlights

  • American Century ETF Trust reported beneficial ownership of 2,945,064 shares, representing 5.1% of Harmony Biosciences Holdings common stock, with sole voting and sole dispositive power over all such shares.
  • American Century Investment Management, Inc. and American Century Companies, Inc. each reported beneficial ownership of 3,113,418 shares, representing 5.4% of the class, with sole voting and sole dispositive power over all such shares.
  • Stowers Institute for Medical Research also reported beneficial ownership of 3,113,418 shares, or 5.4% of the class, with sole voting and sole dispositive power over all such shares.
  • No shared voting or dispositive power was reported by any of the four filers.
  • Triggering event date for the filing was September 30, 2026, according to the statement.
  • American Century Investment Management, Inc. is disclosed as a wholly-owned subsidiary of American Century Companies, Inc., which is controlled by Stowers Institute for Medical Research.

American Century and Stowers Disclose Coordinated Holdings in Harmony Biosciences

According to the Schedule 13G filing, four related entities reported beneficial ownership of common stock in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), whose principal executive offices are located at 630 W Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania, 19462. The event triggering the filing occurred on September 30, 2026, and the statement was signed on November 16, 2026.

The filing discloses that American Century ETF Trust holds 2,945,064 shares, equal to 5.1% of the class, with all voting and dispositive power held solely by that entity. American Century Investment Management, Inc. (ACIM), classified as an investment adviser, and its parent, American Century Companies, Inc. (ACC), each reported the same position of 3,113,418 shares, or 5.4% of the class. Stowers Institute for Medical Research, which the filing describes as controlling ACC, reported the identical 3,113,418-share position at 5.4%.

The filing states that ACIM is "a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940." Regarding the right to receive dividends or sale proceeds, the filing notes that "various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities." The filers certify that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

Four affiliated entities filed a Schedule 13G disclosing beneficial ownership of Harmony Biosciences Holdings common stock as of September 30, 2026. American Century ETF Trust reported 2,945,064 shares (5.1%), while ACIM, ACC, and Stowers Institute each reported 3,113,418 shares (5.4%), all with sole voting and dispositive power.